James Edgemond, CFO AND TREASURER at UNITED THERAPEUTICS Corp (UTHR), sold 10,000 shares at $533.59 ($5.4M) on 2026-06-18, disclosed to the SEC on 2026-06-22.
Scheduled sale ($5.4M) by CFO AND TREASURER under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $533.59 | 400 | $213K | 4.0% |
| 2 | $534.48 | 160 | $86K | 1.6% |
| 3 | $536.27 | 210 | $113K | 2.1% |
| 4 | $537.24 | 600 | $322K | 6.0% |
| 5 | $538.31 | 1,440 | $775K | 14.4% |
| 6 | $539.42 | 2,035 |
| $1.1M |
| 20.3% |
| 7 | $540.22 | 2,978 | $1.6M | 29.8% |
| 8 | $541.06 | 865 | $468K | 8.7% |
| 9 | $541.88 | 192 | $104K | 1.9% |
| 10 | $543.53 | 40 | $22K | 0.4% |
| 11 | $545.19 | 40 | $22K | 0.4% |
| 12 | $547.37 | 265 | $145K | 2.7% |
| 13 | $547.81 | 115 | $63K | 1.2% |
| 14 | $548.90 | 660 | $362K | 6.7% |
| Total | $540.15 avg | 10,000 | $5.4M | 100% |
| Filing → |
| UTHR | SELL | 2026-06-12 | $5.5M | — | Filing → |
| UTHR | SELL | 2026-06-09 | $5.5M | — | Filing → |
| UTHR | SELL | 2026-06-05 | $5.5M | — | Filing → |